{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(7)"],"submitter":["Laniece Delaunay C"],"pubmed_abstract":["<h4>Importance</h4>In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) to inform vaccination campaigns.<h4>Objective</h4>To estimate the effectiveness of COVID-19 vaccines administered in autumn and winter 2022 to 2023 against symptomatic SARS-CoV-2 infection (with all circulating viruses and XBB lineage in particular) among people aged 60 years or older in Europe, and to compare different CVE approaches across the exposed and reference groups used.<h4>Design, setting, and participants</h4>This case-control study obtained data from VEBIS (Vaccine Effectiveness, Burden and Impact Studies), a multicenter study that collects COVID-19 and influenza data from 11 European sites: Croatia; France; Germany"],"journal":["JAMA network open"],"pagination":["e2419258"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11217869"],"repository":["biostudies-literature"],"pubmed_title":["COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans."],"pmcid":["PMC11217869"],"pubmed_authors":["Herrebrugh C","Galindo S","Pedrosa Corral I","Preuss U","Perez Morilla E","Rojo Bello S","Dias D","Garcia Rodriguez MDC","Teirlinck A","Chazelle M","Kissling E","Krisztalovics K","Joyce M","Sluimer J","Botella Quijal F","Mucsanyine Juhasz K","Kager C","de Lange M","Lanca M","Mihin Huskic I","Martinez-Baz I","Wortel S","Nonkovic D","Guerrisi C","Lozano Alonso JE","Barranco MI","Meijer A","Marcos MA","Kosanovic Licina ML","Vega Alonso T","Navascues A","Margolles Martins M","Renard A","Connell J","van der Burgh R","Guiomar R","Andersson E","Jidovu A","Latorre-Margalef N","Kaczmarek M","Ramos Marin V","Hansson-Pihlainen E","Ilic M","Gallardo Garcia V","Biere B","Mendioroz J","Turi G","Durrwald R","Puma T","Gomes L","Rumayor M","Sastre Palou B","Domegan L","Moya Garces A","Vega L","Verdasca N","Samuelsson Hagey T","Gimenez Duran J","Miralles Espi M","Enouf V","Castrillejo D","Casas I","Hansen AL","Moreno Docon A","Dinu S","Basile L","Buda S","Trobajo-Sanmartin C","Ferencak I","Pozo F","Arvesen E","Garcia Comas L","Cusek Adamic K","McKenna A","Goderski G","Pascu C","Fernandez Ibanez A","Dillner L","Kurecic Filipovic S","Rodrigues AP","Lopez Maside A","Oprea M","VEBIS Primary Care Vaccine Effectiveness Group","Dijkstra F","Bacci S","Lopez Causape C","Ezpeleta C","Visekruna Vucina V","Ezpeleta G","Henriques C","Garcia Vazquez M","Bos S","Larrauro A","Masse S","Goerlitz L","Monge S","Oh DY","Andreu Ivorra B","Klinkhamer M","Garcia Cenoz M","Launay T","Mlinaric I","Carnahan A","Nid N","Casado I","Kaic B","Vazquez-Moron S","Sprong T","Kislaya I","Viloria Raymundo LJ","Martinez Mateo AI","Aniceto C","Bistriceanu I","Machado A","Melo A","Jenniskens L","Ordax Diez A","Perez-Gimeno G","Lakoseljac D","Laniece Delaunay C","Oroszi B","Mihai ME","Andreu Salete C","Milagro-Beamonte A","Horvath JK","Falchi A","Ruiz de Porras C","Castilla J","Gomez Anes A","Reiche J","Chirlaque MD","Eggink D","Hooiveld M","Reukers D","Popescu R","Riethof M","Bagheri M","Wedde M","Gomez V","Blanchon T","Bennett C","Lozano Alvarez M","Ivanciuc A","Seve N","Lazar M","Timnea OC","Echeverria A","Mazagatos C","Linares JA","van den Brink S","Kristof K","van Gageldonk-Lafeber R","Sandonis V","Maurel M","Knottnerus B","O'Donnell J","van den Broek R","Veldhijzen N"],"additional_accession":[]},"is_claimable":false,"name":"COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.","description":"<h4>Importance</h4>In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) to inform vaccination campaigns.<h4>Objective</h4>To estimate the effectiveness of COVID-19 vaccines administered in autumn and winter 2022 to 2023 against symptomatic SARS-CoV-2 infection (with all circulating viruses and XBB lineage in particular) among people aged 60 years or older in Europe, and to compare different CVE approaches across the exposed and reference groups used.<h4>Design, setting, and participants</h4>This case-control study obtained data from VEBIS (Vaccine Effectiveness, Burden and Impact Studies), a multicenter study that collects COVID-19 and influenza data from 11 European sites: Croatia; France; Germany","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jul","modification":"2025-04-04T23:55:25.87Z","creation":"2025-04-04T23:55:25.87Z"},"accession":"S-EPMC11217869","cross_references":{"pubmed":["38949812"],"doi":["10.1001/jamanetworkopen.2024.19258"]}}